Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Devon J. Dishman"'
Autor:
Timothy P. Cripe, Joe Conner, Robert Spavin, Kathleen Simpson, Marianne Brunner, Beth Stockman, Lori R. Backus, Devon J. Dishman, Kristy Ott-Napier, Melinda Triplet, Michele R. Vaughan, Alexander J. Towbin, John M. Racadio, Patrick S. Warren, Mark A. Currier, James I. Geller, Keri A. Streby
Supplementary Table S1. Dose administered based on post-injection titers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b0b32762cb0bc9801dc30b0ef67c18
https://doi.org/10.1158/1078-0432.22466724
https://doi.org/10.1158/1078-0432.22466724
Autor:
Timothy P. Cripe, Joe Conner, Robert Spavin, Kathleen Simpson, Marianne Brunner, Beth Stockman, Lori R. Backus, Devon J. Dishman, Kristy Ott-Napier, Melinda Triplet, Michele R. Vaughan, Alexander J. Towbin, John M. Racadio, Patrick S. Warren, Mark A. Currier, James I. Geller, Keri A. Streby
Purpose: HSV1716 is an oncolytic herpes simplex virus-1 (HSV-1) studied in adults via injection into the brain and superficial tumors. To determine the safety of administering HSV1716 to pediatric patients with cancer, we conducted a phase I trial of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c03d81186256f1fe1e3d21f5dfaed99
https://doi.org/10.1158/1078-0432.c.6526407.v1
https://doi.org/10.1158/1078-0432.c.6526407.v1
Autor:
Kathleen Simpson, Michele R. Vaughan, Joe Conner, Devon J. Dishman, Stacy Whiteside, Timothy P. Cripe, Micah Skeens, Nicholas D. Yeager, Keri A. Streby, Mark Ranalli, Bhuvana A. Setty, Kellie B. Haworth, Kristy Ott, Melinda Triplet, Mark A. Currier
Publikováno v:
Molecular Therapy
Seprehvir (HSV1716) is an oncolytic herpes simplex virus-1 (HSV-1) previously demonstrated to be well tolerated in pediatric patients when administered intratumorally. To determine the safety of administering Seprehvir systemically, we conducted the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756b54f6606277b4f2a99db2da5bd902
https://pubmed.ncbi.nlm.nih.gov/31570234
https://pubmed.ncbi.nlm.nih.gov/31570234
Autor:
Kristy Ott-Napier, Kathleen Simpson, Michele R. Vaughan, Lori Backus, John M. Racadio, Patrick Warren, Robert Spavin, Devon J. Dishman, Beth Stockman, James I. Geller, Joe Conner, Keri A. Streby, Marianne M Brunner, Alexander J. Towbin, Mark A. Currier, Timothy P. Cripe, Melinda Triplet
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 23(14)
Purpose: HSV1716 is an oncolytic herpes simplex virus-1 (HSV-1) studied in adults via injection into the brain and superficial tumors. To determine the safety of administering HSV1716 to pediatric patients with cancer, we conducted a phase I trial of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbdea6ef492420a537b187e746a18e49
https://pubmed.ncbi.nlm.nih.gov/28495911
https://pubmed.ncbi.nlm.nih.gov/28495911